Literature DB >> 8811029

Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly.

H Hengel1, T Flohr, G J Hämmerling, U H Koszinowski, F Momburg.   

Abstract

Human cytomegalovirus (HCMV) genes expressed in the early phase of infection mediate the destabilization of nascent major histocompatibility complex (MHC) class I molecules in infected cells and thus prevent antigen presentation to CD8+ T lymphocytes. We report that HCMV genes interfere with the MHC class I pathway of antigen presentation by at least two mechanisms. Firstly, permissive infection of fibroblasts is characterized by a continuous decline in the capacity to translocate peptides from the cytosol into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). Inactivation of peptide transport is operative despite augmented TAP expression during HCMV infection. Secondly, TAP molecules fail to associate with MHC class I heavy chains indicating that HCMV early gene expression also interferes with MHC class I maturation. A temperature-sensitive mutant of HCMV, ts9, which lacks 15 kb of DNA encoding the genes US1-US15 of HCMV, had lost the capacity to interfere with MHC class I assembly and to inhibit the peptide translocation function of TAP. One of the genes deleted in ts9, US11, which was reported to downregulate the expression of MHC class I molecules, does not affect peptide transport by TAP. Therefore, we conclude that HCMV encodes at least two early gene functions that interfere with the MHC class I antigen presentation pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811029     DOI: 10.1099/0022-1317-77-9-2287

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

Authors:  N W Blake; A Moghaddam; P Rao; A Kaur; R Glickman; Y G Cho; A Marchini; T Haigh; R P Johnson; A B Rickinson; F Wang
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.

Authors:  Joanne Trgovcich; Colleen Cebulla; Pete Zimmerman; Daniel D Sedmak
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

5.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

Authors:  P J Lehner; J T Karttunen; G W Wilkinson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Pneumonitis in human cytomegalovirus infection.

Authors:  Erik Langhoff; Robert E Siegel
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

Review 7.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

8.  Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.

Authors:  A Abendroth; I Lin; B Slobedman; H Ploegh; A M Arvin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.

Authors:  T R Jones; L Sun
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.

Authors:  Nagendra R Hegde; Roman A Tomazin; Todd W Wisner; Claire Dunn; Jessica M Boname; David M Lewinsohn; David C Johnson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.